A share price of Abeona Therapeutics Inc [ABEO] is currently trading at $4.53, down -8.30%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ABEO shares have gain 8.11% over the last week, with a monthly amount drifted -18.08%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer started tracking the stock with Outperform rating on March 05, 2025, and set its price target to $16. On July 03, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $15 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $21 on May 30, 2024. Cantor Fitzgerald upgraded its rating to a Overweight but $4 remained the price target by the analyst firm on November 11, 2020. B. Riley FBR started tracking with a Buy rating for this stock on September 18, 2020, and assigned it a price target of $5. In a note dated February 10, 2020, SVB Leerink initiated an Outperform rating and provided a target price of $6 on this stock.
Abeona Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $3.93 and $7.54. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. Abeona Therapeutics Inc [NASDAQ: ABEO] shares were valued at $4.53 at the most recent close of the market. An investor can expect a potential return of 341.5% based on the average ABEO price forecast.
Analyzing the ABEO fundamentals
Gross Profit Margin for this corporation currently stands at 0.27% with Operating Profit Margin at -16.06%, Pretax Profit Margin comes in at 15.95%, and Net Profit Margin reading is 15.89%. To continue investigating profitability, this company’s Return on Assets is posted at 0.36, Equity is 0.78 and Total Capital is -0.4. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.38 points at the first support level, and at 4.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.80, and for the 2nd resistance point, it is at 5.06.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Abeona Therapeutics Inc [NASDAQ:ABEO] is 9.74. As well, the Quick Ratio is 9.53, while the Cash Ratio is 3.74. Considering the valuation of this stock, the price to sales ratio is 580.74, the price to book ratio is 1.39 and price to earnings (TTM) ratio is 3.89.
Transactions by insiders
Recent insider trading involved Alvino Mark, Director, that happened on Nov 13 ’25 when 15000.0 shares were purchased. Chief Executive Officer, Seshadri Vishwas completed a deal on Oct 16 ’25 to sell 249.0 shares. Meanwhile, Officer Seshadri Vishwas bought 249.0 shares on Oct 16 ’25.
